201 related articles for article (PubMed ID: 31011227)
1. Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioral and myelin alterations rescuable by a remyelinating drug.
Barak B; Zhang Z; Liu Y; Nir A; Trangle SS; Ennis M; Levandowski KM; Wang D; Quast K; Boulting GL; Li Y; Bayarsaihan D; He Z; Feng G
Nat Neurosci; 2019 May; 22(5):700-708. PubMed ID: 31011227
[TBL] [Abstract][Full Text] [Related]
2. Neuronal deletion of Gtf2i results in developmental microglial alterations in a mouse model related to Williams syndrome.
Bar E; Fischer I; Rokach M; Elad-Sfadia G; Shirenova S; Ophir O; Trangle SS; Okun E; Barak B
Glia; 2024 Jun; 72(6):1117-1135. PubMed ID: 38450767
[TBL] [Abstract][Full Text] [Related]
3. Intracisternal Gtf2i Gene Therapy Ameliorates Deficits in Cognition and Synaptic Plasticity of a Mouse Model of Williams-Beuren Syndrome.
Borralleras C; Sahun I; Pérez-Jurado LA; Campuzano V
Mol Ther; 2015 Nov; 23(11):1691-1699. PubMed ID: 26216516
[TBL] [Abstract][Full Text] [Related]
4. Consistent hypersocial behavior in mice carrying a deletion of
Martin LA; Iceberg E; Allaf G
Brain Behav; 2018 Jan; 8(1):e00895. PubMed ID: 29568691
[TBL] [Abstract][Full Text] [Related]
5. The contribution of GTF2I haploinsufficiency to Williams syndrome.
Chailangkarn T; Noree C; Muotri AR
Mol Cell Probes; 2018 Aug; 40():45-51. PubMed ID: 29305905
[TBL] [Abstract][Full Text] [Related]
6. Gtf2i and Gtf2ird1 mutation do not account for the full phenotypic effect of the Williams syndrome critical region in mouse models.
Kopp N; McCullough K; Maloney SE; Dougherty JD
Hum Mol Genet; 2019 Oct; 28(20):3443-3465. PubMed ID: 31418010
[TBL] [Abstract][Full Text] [Related]
7. Haploinsufficiency of Gtf2i, a gene deleted in Williams Syndrome, leads to increases in social interactions.
Sakurai T; Dorr NP; Takahashi N; McInnes LA; Elder GA; Buxbaum JD
Autism Res; 2011 Feb; 4(1):28-39. PubMed ID: 21328569
[TBL] [Abstract][Full Text] [Related]
8. Loss of GTF2I promotes neuronal apoptosis and synaptic reduction in human cellular models of neurodevelopment.
Adams JW; Vinokur A; de Souza JS; Austria C; Guerra BS; Herai RH; Wahlin KJ; Muotri AR
Cell Rep; 2024 Mar; 43(3):113867. PubMed ID: 38416640
[TBL] [Abstract][Full Text] [Related]
9. White matter alterations in Williams syndrome related to behavioral and motor impairments.
Nir A; Barak B
Glia; 2021 Jan; 69(1):5-19. PubMed ID: 32589817
[TBL] [Abstract][Full Text] [Related]
10. A Common Polymorphism in a Williams Syndrome Gene Predicts Amygdala Reactivity and Extraversion in Healthy Adults.
Swartz JR; Waller R; Bogdan R; Knodt AR; Sabhlok A; Hyde LW; Hariri AR
Biol Psychiatry; 2017 Feb; 81(3):203-210. PubMed ID: 26853120
[TBL] [Abstract][Full Text] [Related]
11.
López-Tobón A; Shyti R; Villa CE; Cheroni C; Fuentes-Bravo P; Trattaro S; Caporale N; Troglio F; Tenderini E; Mihailovich M; Skaros A; Gibson WT; Cuomo A; Bonaldi T; Mercurio C; Varasi M; Osborne L; Testa G
Sci Adv; 2023 Dec; 9(48):eadh2726. PubMed ID: 38019906
[TBL] [Abstract][Full Text] [Related]
12. Cognitive-behavioral phenotypes of Williams syndrome are associated with genetic variation in the GTF2I gene, in a healthy population.
Crespi BJ; Hurd PL
BMC Neurosci; 2014 Nov; 15():127. PubMed ID: 25429715
[TBL] [Abstract][Full Text] [Related]
13. Essential role of the N-terminal region of TFII-I in viability and behavior.
Lucena J; Pezzi S; Aso E; Valero MC; Carreiro C; Dubus P; Sampaio A; Segura M; Barthelemy I; Zindel MY; Sousa N; Barbero JL; Maldonado R; Pérez-Jurado LA; Campuzano V
BMC Med Genet; 2010 Apr; 11():61. PubMed ID: 20403157
[TBL] [Abstract][Full Text] [Related]
14. Transcription Factor 2I Regulates Neuronal Development via TRPC3 in 7q11.23 Disorder Models.
Deurloo MHS; Turlova E; Chen WL; Lin YW; Tam E; Tassew NG; Wu M; Huang YC; Crawley JN; Monnier PP; Groffen AJA; Sun HS; Osborne LR; Feng ZP
Mol Neurobiol; 2019 May; 56(5):3313-3325. PubMed ID: 30120731
[TBL] [Abstract][Full Text] [Related]
15. GTF2I hemizygosity implicated in mental retardation in Williams syndrome: genotype-phenotype analysis of five families with deletions in the Williams syndrome region.
Morris CA; Mervis CB; Hobart HH; Gregg RG; Bertrand J; Ensing GJ; Sommer A; Moore CA; Hopkin RJ; Spallone PA; Keating MT; Osborne L; Kimberley KW; Stock AD
Am J Med Genet A; 2003 Nov; 123A(1):45-59. PubMed ID: 14556246
[TBL] [Abstract][Full Text] [Related]
16. TFII-I, a candidate gene for Williams syndrome cognitive profile: parallels between regional expression in mouse brain and human phenotype.
Danoff SK; Taylor HE; Blackshaw S; Desiderio S
Neuroscience; 2004; 123(4):931-8. PubMed ID: 14751286
[TBL] [Abstract][Full Text] [Related]
17. Deletion of
Ophir O; Levy G; Bar E; Kimchi Feldhorn O; Rokach M; Elad Sfadia G; Barak B
Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626769
[TBL] [Abstract][Full Text] [Related]
18. Duplication of GTF2I results in separation anxiety in mice and humans.
Mervis CB; Dida J; Lam E; Crawford-Zelli NA; Young EJ; Henderson DR; Onay T; Morris CA; Woodruff-Borden J; Yeomans J; Osborne LR
Am J Hum Genet; 2012 Jun; 90(6):1064-70. PubMed ID: 22578324
[TBL] [Abstract][Full Text] [Related]
19. Altered White Matter and microRNA Expression in a Murine Model Related to Williams Syndrome Suggests That miR-34b/c Affects Brain Development via
Grad M; Nir A; Levy G; Trangle SS; Shapira G; Shomron N; Assaf Y; Barak B
Cells; 2022 Jan; 11(1):. PubMed ID: 35011720
[TBL] [Abstract][Full Text] [Related]
20. Clemastine Enhances Myelination in the Prefrontal Cortex and Rescues Behavioral Changes in Socially Isolated Mice.
Liu J; Dupree JL; Gacias M; Frawley R; Sikder T; Naik P; Casaccia P
J Neurosci; 2016 Jan; 36(3):957-62. PubMed ID: 26791223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
